Status:
NOT_YET_RECRUITING
Abdominal aBscess Catheter Sclerotherapy (ABCS)
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Argon Medical Devices
Conditions:
Abdominal Abscess
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This is a single center, two arm phase I/II clinical trial exploring the use of chemical sclerosants (ethanol and povidone iodine) in decreasing the time needed for catheter drainage for patients with...
Detailed Description
This is a two-arm prospective phase I/II clinical trial to assess the safety of a protocol of catheter-based drainage and povidone iodine or ethanol sclerotherapy of non-fistulous intraabdominal absce...
Eligibility Criteria
Inclusion
- Male or female, aged over 18years
- Cross-sectional imaging (CT, US, MRI) showing an intraabdominal abscess measuring at last 3cm in each dimension without fistula to the bowel or skin.
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
Exclusion
- Pregnancy or lactation
- Known allergic reactions to povidone iodine or ethanol
- Hemodynamic instability
Key Trial Info
Start Date :
July 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06906029
Start Date
July 1 2026
End Date
July 1 2028
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294